TrialPloS one2010

In a subgroup of high-risk Asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events.

Antonio L Dans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.